Aardvark Therapeutics, Inc. (AARD)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 1 signal for Aardvark Therapeutics, Inc.. Most notable: 2026-10-08: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseLee Tien-Li (director) bought $101k of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-11 | Sun Nelson | officer | S | 62,000 | 5.18 | $321,179 |
| 2026-09-10 | Sun Nelson | officer | S | 14,754 | 5 | $73,779 |
| 2025-12-11 | Sun Nelson | officer | P | 3,000 | 14.4 | $43,200 |
| 2025-12-11 | Lee Tien-Li | director | P | 7,000 | 14.49 | $101,430 |
| 2025-12-11 | Sun Nelson | officer | P | 3,000 | 14.4 | $43,200 |
| 2025-12-11 | Lee Tien-Li | director | P | 7,000 | 14.49 | $101,395 |
| 2025-10-15 | Lee Tien-Li | director | M | 1,229 | 4.24 | $5,211 |
| 2025-10-15 | Jones Bryan | officer | M | 1,250 | 4.24 | $5,300 |
| 2025-10-15 | Lee Tien-Li | director | M | 1,229 | 4.24 | $5,211 |
| 2025-10-15 | Jones Bryan | officer | M | 1,250 | 4.24 | $5,300 |
| 2025-09-15 | Lee Tien-Li | director | P | 6,500 | 9.51 | $61,815 |
| 2025-09-15 | Lee Tien-Li | director | P | 3,500 | 9.94 | $34,790 |
| 2025-09-15 | Lee Tien-Li | director | P | 6,500 | 9.51 | $61,819 |
| 2025-09-15 | Lee Tien-Li | director | P | 3,500 | 9.94 | $34,805 |
| 2025-09-12 | Lee Tien-Li | director | P | 5,000 | 8.5 | $42,500 |
| 2025-09-12 | Lee Tien-Li | director | P | 5,000 | 8.5 | $42,516 |
| 2025-09-11 | Lee Tien-Li | director | P | 6,000 | 7.82 | $46,920 |
| 2025-09-11 | Lee Tien-Li | director | P | 6,000 | 7.82 | $46,926 |
| 2025-09-10 | Lee Tien-Li | director | P | 9,000 | 7.91 | $71,190 |
| 2025-09-10 | Lee Tien-Li | director | P | 9,000 | 7.91 | $71,213 |
| 2025-09-09 | Sun Nelson | officer | P | 6,000 | 8.07 | $48,420 |
| 2025-09-09 | Sun Nelson | officer | P | 6,000 | 8.07 | $48,440 |
| 2025-08-28 | Lee Tien-Li | director | M | 17,209 | 4.24 | $72,966 |
| 2025-08-28 | Lee Tien-Li | director | M | 17,209 | 4.24 | $72,966 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | ten percent owner | C | 2,333,887 | — | — |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | ten percent owner | P | 625,000 | 16 | $10,000,000 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | ten percent owner | P | 625,000 | 16 | $10,000,000 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | ten percent owner | C | 333,412 | — | — |
| 2025-02-14 | Chi Jeffrey | director | C | 133,364 | — | — |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | ten percent owner | C | 1,637,411 | — | — |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | ten percent owner | C | 413,491 | — | — |
| 2025-02-14 | Lee Tien-Li | director | P | 16,542 | 16 | $264,672 |
| 2025-02-14 | Lee Tien-Li | director | C | 41,303 | — | — |
| 2025-02-14 | Sun Nelson | officer | P | 10,000 | 16 | $160,000 |
| 2025-02-14 | Sun Nelson | officer | C | 7,001 | — | — |
| 2025-02-14 | Chen Bihua | other | P | 187,500 | 16 | $3,000,000 |
| 2025-02-14 | Chen Bihua | other | C | 800,189 | — | — |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P.; Decheng Capital Management IV (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin | ten percent owner | C | 2,333,887 | — | — |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P.; Decheng Capital Management IV (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin | ten percent owner | C | 333,412 | — | — |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P.; Decheng Capital Management IV (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin | ten percent owner | P | 625,000 | 16 | $10,000,000 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P.; Decheng Capital Management IV (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin | ten percent owner | P | 625,000 | 16 | $10,000,000 |
| 2025-02-14 | Chi Jeffrey | director | C | 133,364 | — | — |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | ten percent owner | C | 1,637,411 | — | — |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | ten percent owner | C | 413,491 | — | — |
| 2025-02-14 | Lee Tien-Li | director | C | 41,303 | — | — |
| 2025-02-14 | Lee Tien-Li | director | P | 16,542 | 16 | $264,672 |
| 2025-02-14 | Sun Nelson | officer | C | 7,001 | — | — |
| 2025-02-14 | Sun Nelson | officer | P | 10,000 | 16 | $160,000 |
| 2025-02-14 | Cormorant Asset Management, LP; Chen Bihua | other | C | 800,189 | — | — |
| 2025-02-14 | Cormorant Asset Management, LP; Chen Bihua | other | P | 187,500 | 16 | $3,000,000 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.